MID2 and cancer: We observed positive correlations between the expression level of TRIM1and the CRC tumor stage (Fig. 4A), the EMT signaling (Fig. 4B), and two malignant tumor marker genes Ki67 and KRAS (Fig. 4C), implying that TRIM1 may play a promotive role in CRC tumorigenesis.